Can text messages help younger latinx adults tame type 2 diabetes?
NCT ID NCT07019649
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
This pilot study tests a 12-week text message program called AYUDA for younger Latinx adults recently diagnosed with type 2 diabetes who are also caring for a child. Participants receive twice-weekly texts with diabetes education and self-management resources. Researchers compare changes in blood sugar levels (HbA1c) between those in the program and those receiving usual care. The goal is to see if this culturally tailored approach is feasible, acceptable, and effective in improving diabetes management.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AYUDA program, a 12-week culturally tailored text message intervention providing diabetes education and self-management resources
- What this could lead to
- If it works, this could point toward a simple, low-cost way to improve diabetes management in younger Latinx adults who are also caregivers.
- What could go wrong
- This is a small pilot study with only 21 participants, so results may not apply broadly. The program's success depends on participants engaging with text messages, and it may not lead to lasting changes in blood sugar control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
21 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 44 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * KPNC member, age \>18 and age \<45 with * New clinical diagnosis of T2D within the prior 6 months * Caregiver to at least one child \<18 years of age at time of diabetes diagnosis * Identifies at Latino/a/x * Can receive text messages * Proficient (written and spoken) in English or Spanish Exclusion Criteria: * Pregnant women * Type 1 Diabetes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus, type 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kaiser Permanente Northern California
Pleasanton, California, 94588, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Effectiveness of shared decision Making(SDM)on patients with poor control type 2 diabetes
- A placebo-controlled, proof-of-concept study to evaluate the safety and efficacy of lanifibranor alone and in combination with the sodium-glucose transport protein 2 (SGLT2) inhibitor EmpaGliflozin in patiEnts with non-alcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM)
- Blood tests may reveal hidden healing power of bone marrow stem cells
- A Finger-Prick at the pharmacy could uncover silent diabetes
- Can a simple fish help tame type 2 diabetes?
- Pharmacies hand out prescriptions for produce to fight diabetes and high blood pressure